Skip to main content
Cambridge University Press - PMC COVID-19 Collection logoLink to Cambridge University Press - PMC COVID-19 Collection
letter
. 2020 May 14:1–7. doi: 10.1017/S0033291720001671

COVID-19 psychological impact in 3109 healthcare workers in Spain: The PSIMCOV group

Carolina S Romero 1, Carlos Delgado 1, Juan Catalá 1,, Carolina Ferrer 1, Carlos Errando 1, Adina Iftimi 2, Ana Benito 3, Jose de Andrés 4, Maria Otero 1; The PSIMCOV group*
PMCID: PMC7477466  PMID: 32404217

Abstract

Background

The current coronavirus disease (COVID-19) has a great impact worldwide. Healthcare workers play an essential role and are one of the most exposed groups. Information about the psychosocial impact on healthcare workers is limited.

Methods

3109 healthcare workers completed a national, internet-based, cross-sectional 45-item survey between 9 and 19 April 2020. The objective is to assess the psychological impact of the COVID-19 pandemic in Spanish healthcare workers. A Psychological Stress and Adaptation at work Score (PSAS) was defined combining four modified versions of validated psychological assessment tests (A) Healthcare Stressful Test, (B) Coping Strategies Inventory, (C) Font-Roja Questionnaire and (D) Trait Meta-Mood Scale.

Results

The highest psychosocial impact was perceived in Respiratory Medicine, the mean (S.D.) PSAS was 48.3 (13.6) and Geriatrics 47.6 (16.4). Higher distress levels were found in the geographical areas with the highest incidence of COVID-19 (>245.5 cases per 100 000 people), PSAS 46.8 (15.2); p < 0.001. The least stress respondents were asymptomatic workers PSAS, 41.3 (15.4); p < 0.001, as well as those above 60 years old, PSAS, 37.6 (16); p < 0.001. Workers who needed psychological therapy and did not receive it, were more stressed PSAS 52.5 (13.6) than those who did not need it PSAS 39.7 (13.9); p < 0.001.

Conclusions

The psychological impact in healthcare workers in Spain during COVID-19 emergency has been studied. The stress perceived is parallel to the number of cases per 100 000 people. Psychotherapy could have a major role to mitigate the experimented stress level.

Key words: Covid-19, healthcare workers, mental health, pandemic, psychological, SARS-CoV-2


Many efforts in the clinical field of the coronavirus disease (COVID-19) are being made. However, mental health is also at stake during this outbreak. Psychological distress is already being detected among the healthcare professionals in Asia (Casas, Repullo, & Lorenzo, 2002; Xiao, Zhang, Kong, Li, & Yang, 2020; Yuan et al., 2020). Information on the psychological impact of healthcare workers is still limited in European countries. Knowledge of this impact is crucial to establish a Mental Health Crisis Response (Pfefferbaum & North 2020). This study describes the psychological stress experimented by the healthcare workers involved in the COVID-19 outbreak in Spain.

This national, internet-based, cross-sectional survey was performed by the Research Institute of the University General Hospital of Valencia, which was the coordinating center for the Psychological Impact of Coronavirus (PSIMCOV) network. For the stress and psychological impact evaluation, four modified versions of validated tests (Appendix 1), were considered to match a context within the extreme shortage of time; (A) Healthcare Stressful Test for identifying stressing factors at work (Cano, Rodríguez, & García, 2007; Carver, Scheier, & Weintraub, 1989), (B) Coping Strategies Inventory for assessing problem solving, self-criticism, emotional expression, willing thoughts, social support, problem avoidance and social support spheres (Aranaz, Mira & Font-Roja Questionnaire, 1988; Salovey, Mayer, Goldman, Turvey, & Palfai, 1995; Tobin, Holroyd, Reynolds, & Kigal, 1989), (C) Font-Roja Questionnaire for assessing satisfaction, pressure, relationships, relaxation, adequacy, control and task variety at work (Fernández-Berrocal & Extremera, 2006) and (D) Trait Meta-Mood Scale for assessing interpersonal aspects of emotional intelligence (Haynes & Lench, 2003; Johnston & Murray, 2003). Every assessed area was represented by at least one question. We defined the Psychological Stress and Adaptation at work Score (PSAS) as a combined measure of the scores obtained in each of the four tests described.

Data were analyzed using the statistical software R (Core Team, 2013). The p values in the tables were calculated with one-way analysis of variance (ANOVA) comparing the mean of PSAS. Variables region and psychotherapy were studied with ANOVA analysis and a Tukey's test for multiple comparisons of means. For the variable Children <12 years old, elderly or handicapped at home, we carried out a t test.

A total of 3109 surveys were analyzed from 9 to 19 April 2020, the most epidemiologically stressful stage of the emergency. Table 1 shows demographics and the main characteristics of the participants of the study. Table 2 shows the global psychological impact results measured by PSAS. Age and the stress perceived, are inversely correlated (p < 0.0001) as seen in a linear regression model reflected in Fig. 1. For analytical purposes, the Spanish geography was divided into five areas based on cumulative incidences defined by the National Health Authority. Healthcare workers in the areas with a higher number of cases (Group V), showed a higher degree of stress globally and in each separated test (p < 0.0001) with a mean (s.d.), PSAS 46.8 (15.2).

Table 1.

Characteristics of the respondents

Characteristic No. % Total
n = 3109
Age mean (s.d.) – year 45.14 (6.48)
Age category – no. (%)
<20 years 2 0.1 2 (0.1%)
20–29 years 350 11.3 350 (11.3%)
30–39 years 737 23.7 737 (23.7%)
40–49 years 895 28.8 895 (28.8%)
50–59 years 781 25.1 781 (25.1%)
60–69 years 334 10.7 334 (10.7%)
⩾70 years 8 0.3 8 (0.3%)
Area – no. (%)*
Group I 105 3.4 105 (3.4%)
Group II 2089 67.2 2089 (67.2%)
Group III 71 2.3 71 (2.3%)
Group IV 369 11.9 369 (11.9%)
Group V 475 15.3 475 (15.3%)
Category – no. (%)
Medical staff 1761 56.6 1761 (56.6%)
Nursing staff 825 26.5 825 (26.5%)
Nurse assistants 238 7.7 238 (7.7%)
Ancillary staff 34 1.1 34 (1.1%)
Administrative staff 48 1.5 48 (1.5%)
Laboratory technicians 24 0.8 24 (0.8%)
Researcher and faculty members 27 0.9 27 (0.9%)
Pharmaceutical representatives 21 0.7 21 (0.7%)
Management staff 12 0.4 12 (0.4%)
Hospital pharmacists 69 2.2 69 (2.2%)
Others 50 1.6 50 (1.6%)
Medical specialty – no. (%)
Allergy 30 1 30 (1%)
Clinical analysis 17 0.6 17 (0.6%)
Pathology 320 10.5 320 (10.5%)
Anesthesiology and Critical Care 766 25.2 766 (25.2%)
Cardiology 52 1.7 52 (1.7%)
Cardiac surgery 48 1.6 48 (1.6%)
General surgery 109 3.6 109 (3.6%)
Orthopedic and trauma medicine 75 2.5 75 (2.5%)
Vascular surgery 13 0.4 13 (0.4%)
Thoracic surgery 17 0.6 17 (0.6%)
Dermatology 21 0.7 21 (0.7%)
Hospital Pharmacy 35 1.2 35 (1.2%)
Gastroenterology 29 1 29 (1%)
Obstetrics and Gynecology 104 3.4 104 (3.4%)
Geriatrics 25 0.8 25 (0.8%)
Hematology 29 1 29 (1%)
Home care doctors 20 0.7 20 (0.7%)
Infectious diseases 14 0.5 14 (0.5%)
Emergency Medicine 135 4.4 135 (4.4%)
Physical medicine and Rehabilitation 31 1 31 (1%)
Intensivists and Critical Care 157 5.2 157 (5.2%)
Internal Medicine 105 3.5 105 (3.5%)
Nephrology 12 0.4 12 (0.4%)
Neurosurgery 29 1 29 (1%)
Neurology 30 1 30 (1%)
Ophthalmology 33 1.1 33 (1.1%)
Medical Oncology 13 0.4 13 (0.4%)
Otorhinolaryngology 31 1 31 (1%)
Others 332 10.9 332 (10.9%)
Pediatrics 131 4.3 131 (4.3%)
Psychiatry 38 1.2 38 (1.2%)
Radiology 72 2.4 72 (2.4%)
Respiratory Medicine 51 1.7 51 (1.7%)
Urology 19 0.6 19 (0.6%)
Workplace
Primary hospital 159 7 159(7%)
Secondary hospital 193 8.5 193 (8.5%)
Tertiary hospital 1185 52.5 1185 (52.5%)
General practitioners in medical centers 293 13 293 (13%)
Ambulance services 429 19 429 (19%)
Seniority
0–1 year 379 12.2 379 (12.2%)
1–3 years 270 8.7 270 (8.7%)
3–5 years 434 14 434 (14%)
5–10 years 302 9.7 302 (9.7%)
10–20 years 872 28 872 (28%)
More than 20 years 849 27.3 849 (27.3%)

*Group I: 19.7–33 cases per 100 000 people.

Group II: 34–70.8 cases per 100 000 people.

Group III: 70.9–117.9 cases per 100 000 people.

Group IV: 118–245.8 cases per 100 000 people.

Group V: 245.9–351.3 cases per 100 000 people.

Table 2.

Psychological impact on the healthcare workers

Test A Test B Test C Test D PSAS p value**
Healthcare stressful factors test Coping strategies inventory Font-Roja Questionnaire Trait meta-mood scale
Subgroup Mean (s.d.)
Age category
20–29 years 5.9 (2.3) 18.5 (6.4) 15.5 (6.3) 6.8 (3.5) 46.7 (14.8) <0.001
30–39 years 5.7 (2.5) 17.1 (6.6) 16.1 (6.5) 6.6 (3.8) 45.5 (15.6)
40–49 years 5.3 (2.5) 16 (6.6) 14.9 (6.5) 5.9 (3.6) 42.1 (15.1)
50–59 years 5.1 (2.3) 14.9 (6.4) 13.2 (6.4) 5.7 (3.6) 38.8 (14.5)
60–69 years 5.1 (2.5) 13.7 (6.6) 13.1 (6.6) 5.7 (3.8) 37.6 (16)
Region <0.001
Group I 4.8 (2.3) 15.4 (6.9) 13.2 (6.8) 5.7 (3.4) 39.1 (15)
Group II 5.3 (2.4) 15.7 (6.7) 14 (6.4) 6.1 (3.7) 41 (15.2)
Group III 5.5 (2.7) 16 (6.7) 15.1 (6.3) 5.1 (3.4) 41.8 (14.9)
Group IV 5.6 (2.4) 15.8 (6.7) 15.6 (6.6) 6.1 (3.7) 43.1 (16.2)
Group V 5.9 (2.5) 17.7 (6.3) 16.5 (6.7) 6.8 (3.8) 46.8 (15.2)
Category
Medical staff 5.4 (2.5) 15.7 (6.7) 15.3 (6.6) 5.9 (3.6) 42.3 (15.8)
Nursing staff 5.7 (2.4) 16.8 (6.4) 14 (6.2) 6.5 (3.7) 43 (14.7)
Nurse assistants 5.1 (2.4) 15.9 (6.9) 13.1 (6.8) 6.5 (4.1) 40.6 (16)
Ancillary staff 5.2 (2.6) 15 (7.1) 13.4 (7.1) 6.4 (4.1) 40 (16.6)
Management staff 4.8 (2.7) 12.4 (7.9) 14.8 (8.6) 4.2 (3) 36.2 (19.7)
Hospital Pharmacists 5.1 (2.5) 16.6 (6.5) 14.1 (6.1) 6.6 (4) 42.3 (14.4)
Medical speciality
Allergy 5.1 (2.5) 16.8 (6.7) 15.6 (6.8) 6.6 (4.1) 44 (15.3)
Clinical analysis 4.8 (2.5) 16.2 (7.4) 13.7 (7.3) 6.9 (3) 41.6 (16)
Anesthesiology and Critical Care 5.7 (2.4) 15.6 (6.5) 15.1 (6.6) 5.8 (3.6) 42.3 (15.6)
Cardiology 5.7 (2.7) 14.9 (6.5) 14.4 (4.9) 6.9 (3.6) 41.9 (13.1)
Cardiac surgery 5.1 (2.1) 14.6 (5.9) 11.6 (6.1) 5.4 (3) 36.7 (13.8)
General surgery 5.2 (2.3) 15.6 (6) 14.5 (6.3) 5.3 (3.8) 40.6 (14.3)
Hospital Pharmacy 4.7 (1.9) 18.9 (6.8) 15.6 (5.2) 7.1 (3.3) 46.3 (13.4)
Gastroenterology 4.1 (2.4) 16.5 (6.3) 16.3 (6) 6.9 (3.2) 43.8 (13.4)
Obstetrics and Gynecology 4.5 (2.1) 14.8 (6.7) 13.7 (6.7) 5.6 (3.9) 38.5 (15.1)
Geriatrics 5.8 (3.4) 17.7 (6.6) 16.6 (6.6) 7.5 (3.8) 47.6 (16.4)
Infectious diseases 5.3 (2.4) 15.8 (8.8) 14.1 (7.9) 7.1 (3.7) 42.2 (20.3)
Emergency Medicine 6.1 (2.2) 17.6 (6.7) 14.2 (6.6) 6.8 (3.6) 44.7 (15)
Physical medicine and Rehabilitation 4.1 (2) 13.4 (7.4) 12.3 (6.8) 5.4 (3.3) 35 (15)
Intensivists and Critical Care 6.1 (2.5) 17.2 (6.3) 15 (5.7) 6.4 (3.6) 44.6 (14.6)
Internal Medicine 5.8 (2.2) 16.6 (6.5) 15 (6.6) 6.1 (3.9) 43.5 (15.2)
Nephrology 4.6 (2.2) 14 (6.6) 15.3 (5.1) 5.1 (3.1) 39 (15.1)
Pneumology 6 (2) 18.7 (6.1) 15.8 (6.4) 7.8 (4.1) 48.3 (13.6)
Neurosurgery 5.6 (2.1) 17.6 (6.1) 13.1 (5.8) 6.5 (3.7) 42.8 (13.5)
Others 5.1 (2.7) 16.3 (7.2) 14.2 (7.2) 6.5 (4) 42.1 (17)
Pediatrics 4.8 (2) 15.6 (6.5) 13.3 (6.2) 6.1 (3.6) 39.8 (15.2)
Psychiatry 4.6 (2.4) 14.1 (7.6) 12.1 (6.7) 4.6 (3.7) 35.4 (17.1)
Ambulance physicians 6.5 (2.7) 17.5 (5.9) 14.4 (6.6) 6.4 (3.8) 44.9 (14.9)
Workplace 0.013
Primary hospital 5.3 (2.4) 15.8 (6.7) 13.8 (6.4) 6.2 (3.7) 41 (15.2)
Secondary hospital 5.4 (2.6) 15.9 (6.6) 15 (6.9) 5.9 (3.6) 42.2 (15.9)
Tertiary hospital 6 (2.6) 16.3 (6.5) 15.6 (7) 6.1 (3.8) 43.9 (16.6)
General practitioners in medical centers 5.3 (2.4) 15.9 (6.7) 14.7 (6.6) 6.1 (3.8) 42.1 (15.6)
Ambulance services 5.5 (2.7) 16.5 (6.5) 15.4 (6.4) 6.3 (3.8) 43.7 (15)

*Group I: 19.7–33 cases per 100 000 people.

Group II: 34–70.8 cases per 100.000 people.

Group III: 70.9–117.9 cases per 100 000 people.

Group IV: 118–245.8 cases per 100 000 people.

Group V: 245.9–351.3 cases per 100 000 people.

** p values correspond to one-way ANOVA comparing the mean of PSAS by each of the categorical variables.

Fig. 1.

Fig. 1.

Linear regression between the variables Age and PSAS.

Tertiary hospital workers showed a higher level of stress, PSAS 43.9 (16.6) along with ambulance services, PSAS 43.7 (15) when compared to other groups (p < 0.0001). Seniority was a protective factor, PSAS 39.1 (15.2) (p < 0.0001). Other elements analyzed that might interfere in the psychological impact experimented are shown in Table 3. Respondents who felt they needed psychological support but did not have the time to receive it, showed a higher degree of stress, PSAS 52.5 (13.6) compared to those who did not need it, PSAS 39.7 (14.9) (p < 0.0001). Asymptomatic workers were less stressed with a PSAS 41.3 (15.4), than the symptomatic group, in isolation, or those who were positive in a COVID-19 test or were hospitalized (p < 0.001). Familiar exposure is also a determinant factor (p < 0.0001). Figure 2 shows a sub-analysis among different healthcare careers and work environment.

Table 3.

Precipitating factors and PSAS

Characteristics No. % Total n = 3109 PSAS Mean (s.d.) p value*
Children <12 years, elderly or handicapped at home 0.684
No 1640 53.4 1640 (53.4%) 42.2 (15.3)
Yes 1429 46.6 1429 (46.6%) 42 (15.7)
Living with your partner 0.096
No 742 23.9 742 (23.9%) 43.1 (15.8)
Yes, not a healthcare worker 1538 49.5 1538 (49.5%) 41.8 (15.1)
Yes, a healthcare worker 829 26.7 829 (26.7%) 41.8 (15.8)
Work environment 0.012
ICU 605 19.5 605 (19.5%) 44.3 (15.4)
Surgery room 599 19.3 599 (19.3%) 40.4 (15.3)
Hospitalization ward 515 16.6 515 (16.6%) 43.3 (15)
Consultations 354 11.4 354 (11.4%) 39.8 (15.6)
Emergency department 316 10.2 316 (10.2%) 45.1 (16)
Other 720 23.2 720 (23.2%) 40 (15.2)
Psychotherapy <0.001
No 2437 78.6 2437 (78.6%) 39.7 (14.9)
No, but I would like to begin 453 14.6 453 (14.6%) 52.5 (13.6)
Yes, I'm in therapy before the crisis 135 4.4 135 (4.4%) 49.2 (15.7)
Yes, I've started therapy since the crisis 2 0.1 2 (0.1%) 55.5 (3.5)
Other, non-conventional therapies 74 2.4 74 (2.4%) 45.4 (13.8)
Personal exposure <0.001
Asymptomatic 1953 63 1953 (63%) 41.3 (15.4)
Symptomatic 704 22.7 704 (22.7%) 43.2 (15.5)
In isolation 344 11.1 344 (11.1%) 44.3 (15.1)
Positive in a test 91 2.9 91 (2.9%) 43.7 (16.1)
I've been hospitalized in a ward 7 0.2 7 (0.2%) 45.9 (10)
I've been hospitalized in the ICU 0 0 0 (0%)
Family exposure <0.001
No 2376 76.7 2376 (76.7%) 41.5 (15.5)
Yes 721 23.3 721 (23.3%) 44.2 (15.4)

*p values correspond to one-way ANOVA comparing the mean of PSAS by each of the categorical variables.

Fig. 2.

Fig. 2.

PSAS career mean by work environment.

The psychological impact of the COVID-19 pandemic in healthcare workers in Spain, has been evaluated. The stress level perceived is predominant in workers that have been in contact directly with COVID-19 patients, like Respiratory Medicine, and in those with family exposure. In the Emergency Medicine (Portero de la Cruz, Cebrino, Herruzo, & Vaquero-Abellán, 2020), workers have also suffered a high impact. This may be indicative that in this environment, COVID-19 exposure is uncertain. The protective effect of seniority may be due to the fact that, expertise and confidence, helps minimizing the stress caused by unforeseen situations. The number of cases in a geographical area was also a conditioning element for the stress. The higher the incidence the disease is, the more stressed the healthcare workers feel (Xiao et al., 2020).

This study has several limitations, the critical nature of the emergency, did not allow to obtain a previous assessment of stress levels or the use of an extended version of the tests. More than 66% of the respondents were working on the second least-affected area, so the reported stress impact could be underestimated.

To the best of our knowledge, this is the largest psychological impact study on healthcare workers during a major pandemic crisis, to date(Kang et al., 2020). Psychological support has demonstrated to minimize the negative impact on healthcare workers. Novel therapy approaches such as on-line support, mindfulness, relaxation therapies, etc. may have a promising role (Xiao, 2020; Yang, Yin, Duolao, Rahman, & Xiaomei, 2020) when the lack of time is a precipitating agent. A second survey will be carry out to assess stress levels among healthcare workers after the crisis finally ends.

Acknowledgments

Conflicts of interest

None.

*PSIMCOV NETWORK

Ricardo Salcedo, MD, Medical Director, Hospital General de Valencia, Valencia (Spain); Pilar Albors, MD, Hospital General de Valencia, Valencia (Spain); Pablo Alcocer, MD, Hospital Nisa 9 de Octubre, Valencia (Spain); Mónica Álvarez, Hospital Universitario de Burgos, Burgos; Mara Andrés, MD, Hospital La Fe, Valencia (Spain); Fernando Antón, Anaford Abogados, Valencia (Spain); Francisco de Asís Aparisi, MD, Hospital General de Valencia, Valencia (Spain); Daniel Arnal, MD, Hospital de Alcorcón, Madrid (Spain); Carmen Baixauli, MD, Hospital General de Valencia, Valencia (Spain); Maria Teresa Ballester, MD, Hospital General de Valencia, Valencia (Spain); Laura Barragán, MD, Centro de salud el Vedat de Torrente, Valencia (Spain); Vibiana Blanco, MD, Centro de salud Trafalgar, Valencia (Spain); Paula Bovaira, Hospital Intermutual, Valencia (Spain); Maria Brugada, MD, Hospital La Fe, Valencia (Spain); Nerea Bueno, MD, SAMU, Valencia (Spain); Antonio Cano, Hospital General de Valencia, Valencia (Spain); Eva Carbajo, Hospital General de Valencia, Valencia (Spain); Beatriz Carrasco, MD, Hospital Virgen de la Luz, Cuenca (Spain); Marta Castell, MD, Hospital La Fe, Valencia (Spain); Isabel Catalá, diseño gráfico, Valencia (Spain); Pablo Catalán, MD; Hospital Arnau de Vilanova, Valencia (Spain); Lucía Cervera, Southport District General Hospital, Liverpool (UK); Irina Cobo, MD, Hospital General de Valencia, Valencia (Spain); Dolores de las Marinas, MD, Hospital General de Valencia, Valencia (Spain); Gema del Castillo, MD, Hospital de Sagunto, Valencia (Spain); Alejandro Duca, MD, Hospital de Manises, Valencia (Spain); Juana María Elía JM, MD, Hospital General de Valencia, Valencia (Spain); Cristina Esteve, Hospital General de Valencia, Valencia (Spain); Silvia Ferri, MD, Hospital de Torrejón, Madrid (Spain); Juana Forner, MD, Hospital General de Valencia, Valencia (Spain); Óscar Gil, MD, Hospital General de Valencia, Valencia (Spain); Marta Gómez-Escolar, MD, Emergencias Sanitarias Castilla y León, Valladolid (Spain); Rosa Hernández, MD, Hospital General de Valencia, Valencia (Spain); Vega Iranzo, MD, Hospital General de Valencia, Valencia (Spain); Raúl Incertis, MD, Hopital de Manises, Valencia (Spain); Ana Izquierdo, MD, Hopital de Manises, Valencia (Spain); María Teresa Jareño, Hospital General de Valencia, Valencia (Spain); Eva Jordá, Hospital General de Valencia, Valencia (Spain); Nela Klein-González, MD, Hospital Clínic de Barcelona, Barcelona (Spain); Pau Klein-González, digital marketing, Valencia (Spain); Amparo Lluch, MD, Hospital General de Valencia, Valencia (Spain); María Dolores López, MD, Hospital General de Valencia, Valencia (Spain); Sara López, MD, Hospital General de Valencia, Valencia (Spain); Eva Mateo, MD, Hospital General de Valencia, Valencia (Spain); Amanda Miñana, MD, Hospital de Gandía, Valencia (Spain); Sergio Mont, Hospital General de Valencia, Valencia (Spain); Maria Carmen Navarro, Researcher, Fundación Hospital General de Valencia (Spain); Pilar Ortega, Hospital General de Valencia, Valencia (Spain); Alessandro Pirola, MD, Hospital General de Valencia, Valencia (Spain); Pablo Renovell, MD, Hospital General de Valencia, Valencia (Spain); Esther Romero, MD, Hospital Clínico de Valencia, Valencia (Spain); Javier Ripollés, Hospital Infanta Leonor, Madrid (Spain); Susana Royo, MD, Hospital General de Valencia, Valencia (Spain); Juan Ramón Ruiz, MD, Hospital General de Valencia, Valencia (Spain); Moisés Sánchez, MD, Hospital General de Valencia, Valencia (Spain); Nerea Sanchís, MD, Hospital General de Valencia (Spain); Francisco Sanz, MD, Hospital General de Valencia, Valencia (Spain); Silvana Serrano, Hospital General de Valencia, Valencia (Spain); Jose Luis Soriano, MD, NHS Bedfordshire Hospitals, Bedford (UK); Ana Tirado, MD, Hospital Infanta Leonor, Madrid (Spain); Francisco Verdú, MD, Hospital General de Valencia, Valencia (Spain); Enrique Zapater, MD, Hospital General de Valencia, Valencia (Spain). In collaboration with SEDAR (Sociedad Española de Anestesia, Reanimación y Terapeútica del dolor), SEPYPNA (Sociedad Española de Psiquiatría y Psicoterapia del Niño y el Adolescente), SENSAR, REDGERM y el COMV (Colegio Oficial de Médicos de Valencia).

Supplementary material

For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0033291720001671.

S0033291720001671sup001.docx (34.1KB, docx)

click here to view supplementary material

References

  1. Aranaz, J., Mira, J., & Font-Roja Questionnaire. (1988). A measurement tool for satisfaction in hospital environment (in Spanish). Todo Hospitales, 52, 63–66. [Google Scholar]
  2. Cano, F. J., Rodríguez, L., & García, J. (2007). Spanish adaptation of coping strategies inventory. Actas Españolas de Psiquiatría, 35(1), 29–39. [PubMed] [Google Scholar]
  3. Carver, C. S., Scheier, M. F., & Weintraub, J. K. (1989). Assessing coping strategies: A theoretically based approach. Journal of Personality and Social Psychology, 56, 267–283. [DOI] [PubMed] [Google Scholar]
  4. Casas, J., Repullo, J. R., & Lorenzo, S. (2002). Stress at work in healthcare environment and adaptative coping strategies (in Spanish). Revista de Calidad Asistencial, 17(4), 237–246. [Google Scholar]
  5. Core Team (2013). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; Retrieved from http://www.R-project.org/. [Google Scholar]
  6. Fernández-Berrocal, P., & Extremera, N. (2006). Emotional intelligence investigation in Spain (in Spanish). Ansiedad y Estrés, 12(2–3), 139–153. [Google Scholar]
  7. Haynes, S., & Lench, H. (2003). Incremental validity of new clinical assessment measures. Psychological Assessment, 15(4), 456–456. [DOI] [PubMed] [Google Scholar]
  8. Johnston, C., & Murray, C. (2003). Incremental validity in the psychological assessment of children and adolescents. Psychological Assessment, 5(4), 496–507. [DOI] [PubMed] [Google Scholar]
  9. Kang, L., Ma, S., Chen, M., Yang, J., Wang, Y., Li, R., & Liu, Z. (2020). Impact on mental health and perception of psychological care among medical and nursing staff in Wuhan during the 2019 novel coronavirus disease outbreak: A cross-sectional study. Brain, Behavior and Immunity, S0889–1591(20), 30348–2. doi: 10.1016/j.bbi.2020.03.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pfefferbaum, B., & North, C.S. (2020). Mental health and the Covid-19 pandemic. New England Journal of Medicine doi: 10.1056/NEJMp2003149. [DOI] [PubMed] [Google Scholar]
  11. Portero de la Cruz, S., Cebrino, J., Herruzo, J., & Vaquero-Abellán, M. (2020). A multicenter study into burnout, perceived stress, job satisfaction, coping strategies, and general health among emergency department nursing staff. Journal of Clinical Medicine, 9(4), E1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Salovey, P., Mayer, J., Goldman, S., Turvey, C., & Palfai, T. (1995). Emotional attention, clarity, and repair: Exploring emotional intelligence using the trait meta-mood scale In Pennebaker J. (Ed.), APA Science volume series (pp. 125–154). Washington, DC: American Psychological Association. [Google Scholar]
  13. Tobin, D. L., Holroyd, K. A., Reynolds, R. V., & Kigal, J. K. (1989). The hierarchical factor structure of the coping strategies inventory. Cognitive Therapy Research, 13(4), 343–361. [Google Scholar]
  14. Xiao, C. (2020). A novel approach of consultation on 2019 novel coronavirus (COVID-19)-related psychological and mental problems: Structured letter therapy. Psychiatry Investigation, 17(2), 175–176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Xiao, H., Zhang, Y., Kong, D., Li, S., & Yang, N. (2020). The effects of social support on sleep quality of medical staff treating patients with coronavirus disease 2019 (COVID-19) in January and February 2020 in China. Medical Science Monitor, 26, e923549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Yang, L., Yin, J., Duolao, W., Rahman, A., & Xiaomei, L. (2020). Urgent need to develop evidence-based self-help interventions for healthcare workers in COVID-19 pandemic. Psychological Medicine, 28, 1–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Yuan, S., Liao, Z., Huang, H., Jiang, B., Zhang, X., Wang, Y., & Zhao, M. (2020). Comparison of the indicators of psychological stress in the population of Hubei province and non-endemic provinces in China during two weeks during the coronavirus disease 2019 (COVID-19) outbreak in February 2020. Medical Science Monitor, 26, e923767. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0033291720001671.

S0033291720001671sup001.docx (34.1KB, docx)

click here to view supplementary material


Articles from Psychological Medicine are provided here courtesy of Cambridge University Press

RESOURCES